Project Grant R01HL171207
Award Date
8/15/24
Completion Date
5/31/27
Dollars Obligated
$807K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI, CFDA 93.837 Cardiovascular Diseases Research) provides $185,579 to The University of Texas Southwestern Medical Center to conduct research on pre-transplant biomarkers for predicting rejection risk in heart transplant recipients. The key research activities include: Validating three protein biomarkers (FGF-2, SPRTY-2, IRAK-1) associated with rejection and expanding proteomic profiling on the Olink...
This $1,411,136 Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) aims to characterize circadian rhythms in organ donors and identify mechanisms by which donor and recipient circadian clocks affect organ transplant acceptance. The primary focus is on the lung, where long-term survival after transplantation remains poor (median ~5 years). The grant has two key objectives: 1) Develop a model to predict donor biological rhythms and...
This Project Grant award of $182,689 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under CFDA program 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research) will fund research on survivorship trajectories after liver transplantation. The grant aims to: 1) characterize distinct post-liver transplant survivorship phenotypes, 2) investigate the relationship between survivorship phenotypes and outcomes like medication adherence and quality of...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $804,438 project grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Inova Health Care Services, doing business as Inova Fairfax Hospital, a non-profit healthcare organization in Virginia. The grant funds a 5-year study to develop and validate a panel of circulating microRNAs that can quantify the net immune state of heart transplant patients. The goal is to create a non-invasive blood test to monitor...
This Project Grant award for $1,919,946 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research to assess the impact of antihypertensive medications on cardiovascular and renal outcomes in patients with chronic kidney disease (CKD). The project aims to leverage data from the Chronic Renal Insufficiency Cohort (CRIC) and Systolic Blood Pressure Intervention Trial (SPRINT) to estimate and compare the effects of...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), provides $651,840 to the University of Toledo Health Science Campus to develop a urine-based Kidney Tubule Health Panel (KTHP) biomarker system. The goal is to better monitor kidney health during treatment for resistant hypertension, as changes in creatinine levels can often lead to interruption of effective blood pressure...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), part of the Cardiovascular Diseases Research program (CFDA 93.837), provides $191,777 to the University of California, Davis (UC Davis) to develop a personalized approach for determining optimal blood pressure (BP) targets. The key objectives are to: 1) refine predictive models that estimate an individual's change in cardiovascular disease risk with intensive vs. standard BP lowering; 2) characterize patient...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a 7-year, $564,445 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to the University of Texas Health Science Center at Houston (UTHealth) to advance research on targeting hypoxia-inducible factors (HIFs) for heart and lung disease. This grant supports three complementary research projects focused on: 1) the regulation of HIFs by prolyl hydroxylase domain enzymes (PHDs) during acute respiratory distress syndrome...
This Project Grant award of $798,958 from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), supports research to understand the molecular mechanisms linking acute lung injury after transplantation to the development of chronic lung allograft dysfunction. The research will be conducted by Northwestern University and aims to determine whether activation of the integrated stress response in the airway and alveolar epithelium...
This $5,187,690 Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports a research program focused on advancing the understanding of ABO(H) blood group antigens and corresponding anti-ABO(H) antibodies. The program aims to define the factors that govern anti-ABO(H) antibody formation and the specific ABO(H) antigen targets responsible for hemolytic transfusion reactions. The research program involves three distinct projects...